Basic Information
| RNALocate ID: | RLID:11003186 |
| RNA Symbol: | hsa-miR-493-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-493-3p |
| RNA ID: | miRBase:MIMAT0003161 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003185 | Exosome | Brain tissue | 23382797 |
| RLID:11003187 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11003188 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000507 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001313 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-493-3p | Oral squamous cell carcinoma | MNDR-E-MI-54365 |
| MNDR | hsa-miR-493-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-54366 |
| MNDR | hsa-miR-493-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54367 |
| MNDR | hsa-miR-493-3p | Lymphoma | MNDR-E-MI-54368 |
| MNDR | hsa-miR-493-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54369 |
| MNDR | hsa-miR-493-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-54370 |
| MNDR | hsa-miR-493-3p | Prostate cancer | MNDR-E-MI-54371 |
| MNDR | hsa-miR-493-3p | Gastric cancer | MNDR-E-MI-54372 |
| MNDR | hsa-miR-493-3p | Alzheimer disease | MNDR-E-MI-54373 |
| MNDR | hsa-miR-493-3p | Bladder cancer | MNDR-E-MI-54374 |
| MNDR | hsa-miR-493-3p | Dysautonomia familial | MNDR-E-MI-54375 |
| MNDR | hsa-miR-493-3p | Duchenne muscular dystrophy | MNDR-E-MI-54376 |
| MNDR | hsa-miR-493-3p | Head and neck cancer | MNDR-E-MI-54377 |
| MNDR | hsa-miR-493-3p | Leukemia | MNDR-E-MI-54378 |
| MNDR | hsa-miR-493-3p | Lung cancer | MNDR-E-MI-54379 |
| MNDR | hsa-miR-493-3p | Parkinson disease | MNDR-E-MI-54380 |
| MNDR | hsa-miR-493-3p | Breast cancer | MNDR-E-MI-54381 |
| MNDR | hsa-miR-493-3p | Neuroendocrine neoplasia | MNDR-E-MI-54382 |
| MNDR | hsa-miR-493-3p | Pituitary neoplasms | MNDR-E-MI-54383 |
| MNDR | hsa-miR-493-3p | Pancreatic cancer | MNDR-E-MI-54384 |
| MNDR | hsa-miR-493-3p | Melanoma | MNDR-E-MI-54385 |
| MNDR | hsa-miR-493-3p | Rectum adenocarcinoma | MNDR-E-MI-54386 |
| MNDR | hsa-miR-493-3p | Nephroblastoma | MNDR-E-MI-54387 |
| MNDR | hsa-miR-493-3p | Colon cancer | MNDR-E-MI-54388 |
| MNDR | hsa-miR-493-3p | Colon adenocarcinoma | MNDR-E-MI-54389 |
| MNDR | hsa-miR-493-3p | Ovarian cancer | MNDR-E-MI-54390 |
| MNDR | hsa-miR-493-3p | Prostate adenocarcinoma | MNDR-E-MI-54391 |
| MNDR | hsa-miR-493-3p | Carcinoma ductal breast | MNDR-E-MI-54392 |
| MNDR | hsa-miR-493-3p | Glioblastoma | MNDR-E-MI-54393 |
| MNDR | hsa-miR-493-3p | Malignant glioma | MNDR-E-MI-54394 |
| MNDR | hsa-miR-493-3p | Nemaline myopathy | MNDR-E-MI-54395 |
| MNDR | hsa-miR-493-3p | Epilepsy temporal lobe | MNDR-E-MI-54396 |
| MNDR | hsa-miR-493-3p | Osteosarcoma | MNDR-E-MI-54397 |
| MNDR | hsa-miR-493-3p | Breast carcinoma | MNDR-E-MI-54398 |
| MNDR | hsa-miR-493-3p | Cervical adenocarcinoma | MNDR-E-MI-54399 |
| MNDR | hsa-miR-493-3p | Gastric adenocarcinoma | MNDR-E-MI-54400 |
| MNDR | hsa-miR-493-3p | Lung adenocarcinoma | MNDR-E-MI-54401 |
| MNDR | hsa-miR-493-3p | Adrenocortical carcinoma | MNDR-E-MI-54402 |
| MNDR | hsa-miR-493-3p | Thyroid carcinoma | MNDR-E-MI-54403 |
| MNDR | hsa-miR-493-3p | Ovarian carcinoma | MNDR-E-MI-54404 |
| MNDR | hsa-miR-493-3p | Bladder urothelial carcinoma | MNDR-E-MI-54405 |
| MNDR | hsa-miR-493-3p | Pancreatic adenocarcinoma | MNDR-E-MI-54406 |
| MNDR | hsa-miR-493-3p | Carcinoma renal cell | MNDR-E-MI-54407 |
| MNDR | hsa-miR-493-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54408 |
| MNDR | hsa-miR-493-3p | Renal clear cell carcinoma | MNDR-E-MI-54409 |
| MNDR | hsa-miR-493-3p | Esophageal cancer | MNDR-E-MI-54410 |
| MNDR | hsa-miR-493-3p | Synovial sarcoma | MNDR-E-MI-54411 |
| MNDR | hsa-miR-493-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-54412 |
| MNDR | hsa-miR-493-3p | Breast invasive carcinoma | MNDR-E-MI-54413 |
| MNDR | hsa-miR-493-3p | B-cell lymphoma | MNDR-E-MI-54414 |
| MNDR | hsa-miR-493-3p | Rheumatoid arthritis | MNDR-E-MI-54415 |
| MNDR | hsa-miR-493-3p | Barrett's adenocarcinoma | MNDR-E-MI-54416 |
| MNDR | hsa-miR-493-3p | Colorectal cancer | MNDR-E-MI-54417 |
| MNDR | hsa-miR-493-3p | Barrett's carcinogenesis | MNDR-E-MI-54418 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | DKK1 | Homo sapiens | RR00442070 |
TOP